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AbstrACt
Objectives This study explored citizens’ perspectives 
about the quality of community pharmacy services in 
the UK and whether and how the quality of community 
pharmacy services should be measured.
Design Semistructured interviews and focus groups 
were conducted and were audio recorded, transcribed 
and analysed systematically using an interpretive 
approach.
Participants Members of the public were approached 
via networks, such as Health and Social Care Alliance 
Scotland, as well as community groups and personal 
networks.
setting Scotland, England and Wales.
results Data were collected from 20 participants: 
11 interviews and 2 focus groups (in community 
settings, with five and four participants). Quality 
was conceptualised as multidimensional with inter-
related overarching themes of person-centredness, 
professionalism and privacy. The importance of 
relational aspects with pharmacy personnel was 
emphasised including the need for a ‘friendly’ caring 
service, continuity of care, being known to personnel, 
including their awareness of individual’s health 
conditions: ‘it’s quite a personal service I would say…I 
think it means that they care about your welfare’. 
Participants discussed the importance of a professional 
approach to customer interactions including staff 
behaviour and appearance. Pharmacy design influenced 
perceptions of privacy, including having sufficient space 
or a separate consultation room to promote confidential 
consultations with a pharmacist. Participants suggested 
that quality assurance is needed to improve quality 
and to inspire confidence in the public ‘it would drive 
up quality standards overall’ but suggested that 
quality ratings were unlikely to influence their use of 
specific pharmacies. They emphasised the need for 
multidimensional quality ratings and for transparency 
with their derivation.
Conclusions The public conceptualises quality of 
community pharmacy services as multidimensional and 
value relational aspects of care provided by personnel 
in this setting. While the development and application 
of quality indicators may drive improvement, it seems 
unlikely to influence the public’s use of individual 
pharmacies.
IntrODuCtIOn  
Each year in the UK, an estimated 650 000 
emergency department consultations and 
18 million general practitioner consulta-
tions are for conditions (hereafter referred 
to as self-care consultations) that can be 
treated effectively by community pharmacy 
personnel, equating to around £1.1 billion in 
resources.1–2 In England, each of the 11 699 
community pharmacies3 serves an average 
population of around 5600 citizens4 of whom 
an estimated 89% are within a 20 minute walk 
of a community pharmacy.5 National policies 
and resources recommend the public to seek 
care from the most ‘appropriate’ provider.6–8 
Reassurance is needed regarding the quality 
of care provided in community pharmacies 
in general, and more specifically for self-care, 
which has been shown to vary, depending on 
the criteria used.9–11 While national quality 
indicators for community pharmacy were 
introduced in England in 201712, none refer 
to the management of self-care consultations 
despite this service being regarded the ‘shop 
window’ of community pharmacy.13 As such, 
the study presented here is part of a research 
programme to coproduce quality indicators 
for self-care consultations.
strengths and limitations of this study
 ► A diverse range of individuals participated in terms 
of age, sex and country but not ethnicity.
 ► Data collection was undertaken by one experi-
enced health service researcher who was also a 
pharmacist
 ► Data analysis was undertaken by two experienced 
qualitative researchers neither of whom were phar-
macists. This ensured a balanced approach to the 
analysis and interpretation of the data.
 ► All key recurring themes were identified with no new 
themes emerging in later interviews or focus groups.
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The aim of this study was to conceptualise public 
perceptions and beliefs about the:
 ► Quality of community pharmacy services in general.
 ► Management of self-care consultations.
 ► Measurement of the quality of community pharmacy 
services.
MethODs
study design
Interviews and focus groups were conducted with 
members of the public with the method used varying 
according to participant availability and preference.
recruitment, sampling and consent
Participants were recruited through existing networks 
such as Health and Social Care Alliance Scotland,14 as 
well as community groups and personal networks. Indi-
viduals were eligible to participate if they used commu-
nity pharmacy services, and understood and were able to 
communicate in English. An email was sent to potential 
participants with information about the study, advising 
them to contact the research team if they wished to partic-
ipate. Recruitment ceased once theoretical saturation was 
reached (ie, when no new themes were emerging from 
the data). A maximum variation sample was recruited 
using a combination of purposive, convenience and snow-
balling techniques.15
Data collection
One female researcher (MW), who is a registered pharma-
cist with 25 years' experience of health services research, 
undertook all data collection. Audio-recorded face-to-
face or telephone interviews were conducted between 
August 2016 and July 2017, and lasted an average of 
51 minutes (range 31–74 minutes). No other individuals 
were present during the interviews or focus groups. The 
topic (interview) guide was informed by existing work 
on quality and quality improvement, as well as a prece-
dent interview study involving pharmacists.13 It was not 
piloted prior to use but was modified throughout the data 
collection process to incorporate relevant topics identi-
fied in earlier interviews and focus groups. This is consis-
tent with an inductive approach in which theory emerges 
iteratively and develops through the analysis of data. 
The concepts of ‘what matters to you’, ‘always events’ 
and ‘never events’ were included.13 16 Always events are 
‘aspects of the patient experience that are so important 
to patients and families that healthcare providers must 
aim to perform them consistently and reliably for every 
patient, every time’.17
Quality measurement was explored in general terms 
and more specifically in relation to the use of rating or 
accreditation systems. The same topic guide was used 
for interviews and focus groups. As new issues or themes 
emerged, they were included in subsequent interviews/
focus groups. On completion of the interviews/focus 
groups, participants were offered a ‘thank you’ voucher 
worth £20.
Data analysis
Audio recordings were transcribed verbatim by an expe-
rienced transcriber and accuracy checked (KS/RW). The 
data were analysed systematically using thematic anal-
ysis.18–19 The focus of the analysis was to organise the data 
in a meaningful way according to the a priori aims of the 
study, as well as to allow for the identification of topics 
and issues of importance to participants. NVivo V.11 
(QSR International) was used to help organise, code and 
explore the data. Two researchers (KS, RW) first familia-
rised themselves with the transcripts and coded to broad 
topic areas (structuring codes). The next (extensive and 
iterative) phase involved the identification of themes 
and subthemes to reflect the research questions (a priori 
codes/nodes) and from within the data itself (in vivo 
codes/nodes). As the analysis progressed, conceptual and 
cross-cutting themes were identified and coded, in addi-
tion to relevant topic codes.
Each transcript was coded by one researcher (KS or 
RW), with most coded by two researchers (KS, RW) to 
ensure reliability. The themes, their names and expla-
nations were continually refined through discussion 
between the researchers to ensure that they were distinct 
from other themes, internally coherent and consistently 
applied. The coded data were explored through queries 
and other NVivo tools, and themes were mapped to iden-
tify connections. Once coding was complete, a framework 
approach20 was used to support the systematic analysis of 
data around the research questions, to enable an assess-
ment of prevalence and coverage of key themes (ie, 
dimensions of quality). Further interpretation and discus-
sion, to ensure that analytical claims were congruent with 
the extracts, culminated in the creation of a thematic 
resource document. This reported all the relevant coded 
data under overarching themes/headings, with some 
extracts being duplicated under two or more themes 
(eg, in the case of richness or complexity). This study 
is reported in accordance with Consolidated criteria for 
Reporting Qualitative research21.
Patient and public involvement statement
We did not involve patient and public involvement (PPI) 
representatives in the development of the research ques-
tions and outcome measures or in the design of the study. 
However, patients and the public were recruited through: 
the Scottish Patient Alliance; two participants in England 
were recruited through PPI groups; and the English and 
Welsh focus group participants were recruited through 
professional contacts of the researchers. Study results 
will be disseminated to all participants who expressed 
an interest in being informed of the results using a plain 
language summary that will be sent via email or in the post. 
All participants were thanked in the acknowledgements.
results
In total, 20 individuals participated (Scotland (n=7) all 
interviewed individually; England (one focus group (n=4) 
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and four individual interviews (one of which was face to 
face)); and Wales (one focus group (n=5)) (table 1). The 
majority were British and female. Four participants had 
been employed previously in health-related employment 
(none reported pharmacy-related employment although 
one male sometimes worked as a delivery driver for a 
local pharmacy). The focus group in England comprised 
four women in their 30s, all parents of young children. 
The focus group in Wales comprised three women in 
their 40s and 50s who were all mothers, and two grad-
uate students in their 20s. All seven participants in Scot-
land were recruited through the Scottish Patient Alliance, 
two participants in England were recruited through PPI 
groups, and the English and Welsh focus group partici-
pants were recruited through professional contacts of the 
researchers (MW, RW).
Dimensions of quality: the three P’s
When asked ‘what matters to you’, participants concep-
tualised the quality of community pharmacies as multi-
dimensional and inter-related with three overarching 
themes: person-centredness, professionalism and privacy. 
Selected quotes are presented to illustrate these dimen-
sions and themes (Identifiers I and F denote interview 
and focus group participants, respectively).
Person-centredness
Participants emphasised the importance of relational 
aspects with pharmacy personnel including the need for 
a ‘friendly’ caring service, continuity of care and the staff 
‘knowing’ the individual, including awareness of their 
health conditions.
I4: The staff are really friendly, and helpful,… it's 
quite a personal service I would say…I think it means 
that they care about your welfare.
I8: I like continuity… It makes me feel safer, and 
um…it's like your doctor, you want your doctor to 
know you… it's nice to think that this person knows 
you and might actually take an interest in you as op-
posed to you’re just the next customer.
They generally wanted easy access to a pharmacist and 
pharmacies in terms of geographical proximity and loca-
tion, as well as opening hours, which suited their needs 
and lifestyle, and suitable parking or access by public 
transport. However, others were willing to travel further 
for specific medication needs or a better service.
Some also wanted the pharmacist to be visible and 
accessible in the pharmacy.
I9:…direct access, easy access to the pharmacist (…) 
because there are some pharmacists [sic] you go to 
Table 1 Participant characteristics
Identifier Country Ethnicity Male/Female Range
Healthcare 
background
I1 Scotland White Scottish Female 50–59 NS
I2 Scotland Irish Female 60–69 Yes (retired)
I3 Scotland White Scottish Female 40–49 NS
I4 Scotland White Scottish Female 20–29 No
I5 Scotland White British Female 50–59 NS
I6 Scotland White Male 70–79 No
I7 Scotland British Male 70–79 Yes
I8 England White British Female 70–79 Yes
I9 England White British Male 60–69 No
I10 England British Male 70–79 No
I11 England White Female 50–59 No
F1_1 England British Female 30–39 No
F1_2 England British Female 30–39 No
F1_3 England White British Female 30–39 No
F1_4 England British Female 30–39 No
F2_1 Wales British Female 50–59 No
F2-2 Wales White European Female 20–29 No
F2_3 Wales White British Male 20–29 No
F2_4 Wales NS Female 40–49 No
F2_5 Wales White British Female 40–49 Yes
I, interview; F, focus group; NS, not stated.
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where the registered pharmacists is like someone hid-
ing behind…a curtain and you don’t see them.
F1_1: They [counter staff] are the gatekeepers aren’t 
they?. .the pharmacist is in the back, somewhere you 
know? It does feel like you have to have something 
really legitimate to speak to them rather than them 
being available to speak to you (…). I don’t know the 
rules. I would like to know the answer to that —when 
am I entitled to speak to the pharmacist?
Interviewees felt that staff should take time to listen and 
communicate clearly, involve people in decisions around 
their own treatment, be responsive to personal require-
ments and preferences and be respectful of individual 
concerns.
I10: [there should always be] a feeling that the per-
son you are talking to has time for you obviously. If 
you have the feeling that you are being a nuisance 
then you would be reluctant to ask a second time.
Professionalism
Participants discussed the importance of a professional 
approach in customer interactions including staff 
behaviour and appearance. Although not all expected 
staff to wear a uniform, it was commonly felt that they 
should be identifiable, for example, by wearing name 
badges.
I11: The staff would look clean and smart and pre-
sentable and the name badge confirming that they 
are not just Saturday girls, they are kind of trained 
professionals.
F1_2: I guess maybe for them to tell you who they 
are—introduce themselves. ‘I am a pharmacist’ or—
so that you know exactly who you're dealing with.
People expected staff (including, but not only, phar-
macists) to be competent, suitably trained, qualified 
and confident in their ability to diagnose, advise and 
prescribe, and for all staff to be knowledgeable about 
over-the-counter medication (ie, medicines, which can be 
sold/bought without the need for a prescription), and be 
able to provide (cheaper) alternatives.
F2_3: If they are still uncertain they should always re-
fer you back to your GP
F1_3: I don’t know if it was the pharmacist or the 
pharmacy assistant to be honest but she basically ad-
vised me to take a slightly cheaper model of the med-
icine… . . And I really appreciated it, that's a nice 
thing to do.
Counter staff were expected to defer to the pharma-
cist if necessary, who should then refer onward as ap-
propriate, but not be overly risk averse (a frustration 
for parents of young children).
F1_2: [I] went a few times when [name of child] was 
younger and then because I just kept getting…’I 
don’t know what's wrong with him, he's got like a bit 
of a rash, or something, is there anything you can give 
me?’ and they were like ‘oh we wouldn’t like to say 
just go and see the GP’. Now… I will go straight to the 
GP. .because…they don’t ever seem keen to actually 
sort of [sic] not diagnose.
Participants felt it was important that a pharmacy felt 
clean, light and ‘hygienic’. It was felt that a good quality 
pharmacy should have sufficient medication stock so that 
prescriptions could be fully filled, in a timely manner, to 
avoid return visits.
I6: It's got to be how quickly you receive whatever 
medicine or treatment you need… that's the most 
important thing.
Privacy
Privacy was an important consideration and included 
physical characteristics of the pharmacy in supporting 
privacy, with either a separate consultation room or a 
dedicated private area, and the need to have confidential 
conversations with the pharmacist.
I2: Private consultation room that's accessible. Not at 
the back of the shop (…) I don’t think there should 
be over the counter consultations at the same section 
where people are coming to buy their cosmetics or 
whatever or pick up their prescriptions…it should be 
separate, in fact go into  [ supermarket pharmacy ]  you've 
got to queue up with everybody that's wanting their fags, or 
wants a lottery ticket.
Privacy was interwoven with confidentiality, which 
in turn, influenced confidence and trust in pharmacy 
personnel.
I11:…they reassure you…()…you that it is a private 
consultation maybe and that your data is protected as 
a minimum I suppose.
I5: We do have a village pharmacy, but because of 
the lack of confidentiality I am now taking myself a 
52 mile round trip to get a prescription…() It matters 
that I feel confident in the service that I'm being 
given, that I'm confident in the fact that my infor-
mation is being kept confidential, and that the fact 
is that the pharmacists on the whole genuinely are 
trying to do their best by patients.
Measuring quality in community pharmacies
Participants were asked whether the quality of community 
pharmacies should be measured and if so, what measures 
to use. Participants suggested that quality assurance is 
needed to improve quality as well as to inspire confidence 
in the public.
I5:. .the only way you're going to know that you're go-
ing to get a good service is to actually publish the fact 
that you are getting a good service. It's like in hospital 
wards for cleanliness, now they're putting up figures 
showing that they've managed to eliminate for the 
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last 100 days—they've had no MRSA—that gives con-
fidence to patients when they read that and see these 
facts and figures. And they're put out there for every-
body to see not just the few, that's important.(…). it 
would be about saying to the good pharmacists ‘well 
done you're getting it right every time’. But it's also 
saying to the other ones ‘you need to pull your socks 
up’.
There was recognition that quality could be difficult to 
measure across varied services and discussion of which 
criteria to use.
F2_4: How effective was the information or how accu-
rate was the information you received, did it work for 
you, was it right or was it wrong or, how satisfied were 
you on what you were told, and I think that’s it in a 
nutshell really.(…)
Suggested methods of quality measurement included: 
customer satisfaction surveys/instant feedback; audit; 
mystery shoppers and the use of professional stand-
ards. The use of rating systems was explored specifically. 
Participants identified similar systems associated with 
other aspects of life, including: shopping (Amazon); 
travel (Trip Advisor); restaurants (food hygiene ratings); 
health (hospital wards) and education services (Ofsted 
(Office for Standards in Education)). Many partici-
pants expressed broadly positive attitudes towards rating 
systems, while others questioned their usefulness based 
on the use of similar systems applied to other areas, for 
example, education. The relevance of these systems to 
community pharmacies was also questioned due to the 
more complex, less ‘transactional’ element of service/
customer interaction.
I9: There are ratings systems for things that—where 
a service can damage the public…(). we already 
have food safety ratings for cafes and restaurants. 
One might ask why we don’t have one for something 
where the service could kill you more effectively, or 
more easily.(). you can tell a reasonable restaurant or 
cafe from your first consumer experience, you won't 
necessarily know a really good pharmacy from a less 
than good pharmacy.
Participants described potential positive, negative and 
unintended consequences of a star-type rating system for 
reporting quality.
I4: I think it would drive up quality standards overall. 
Yeah, I think it would be a good measure. If chemists 
know that they're being rated they obviously wouldn’t 
want a bad rating.
I8:. . I realise how frightened people are of their 
health…so I think if they went into a chemist shop 
and saw that maybe it only had 3 and room for im-
provement, I think they'd [the public] get nervous 
about that. So yes, there can be a rating but I don’t 
think it really needs to be displayed when it comes to 
health.
Some participants considered rating systems to be too 
subjective.
F2_1:. . if it was general public rating then I’d be a bit 
sceptical but if it came from a professional going in 
and give it an accredited, like the scores on the door, 
like it comes from a governing body … then I would 
have more tendency to go with what they said, . . a 
non-biased organisation. . and you were judged (…) 
Maybe give it different categories, maybe the custom-
er service side ask the general public, but as far as the 
professional—the accuracy of what was given out and 
the way everything was kept—leave that part to the 
professionals because I wouldn’t be anyone to judge.
Most participants stated that they would take notice 
of star ratings if they existed, but would not necessarily 
base their choice of pharmacy on them. Some preferred 
to make their own judgement. For most, the decision to 
use a particular pharmacy was contingent on a number 
of potentially overlapping factors including accessibility, 
personal needs, time available and perceived urgency. 
Given that most also expressed general satisfaction with 
the pharmacy they used, and some had no realistic choice 
of using another, there was some scepticism around the 
value of a star ratings type system in terms of what it might 
be based on and how it would be used.
F2_2: It wouldn’t affect my choice of the pharmacy 
unless it was maybe a one star out of five then I’d 
be like well ‘what’s going on here like why’ but if 
it was four or three I’d probably wouldn’t care be-
cause I probably wouldn’t understand what the rat-
ing is based on, who gave this rating to this particular 
pharmacy. I mean in restaurants I know that if the 
hygiene—so I can imagine what it means—but in a 
pharmacy, but is it the customer service, is it the way 
they organise their medicines, I’d probably just base 
my choice—based on my experience.
DIsCussIOn
statement of principal findings
Quality was conceptualised as multidimensional with 
inter-related overarching themes of person-centredness, 
professionalism and privacy. The importance of relational 
aspects with pharmacy personnel was emphasised. Partic-
ipants valued a professional approach including staff 
behaviour and appearance. Pharmacy design influenced 
perceptions of privacy, including having sufficient space 
or a separate consultation room to promote private and 
confidential consultations with a pharmacist.
Participants suggested that quality assurance would 
‘drive up quality standards overall’ and inspire confidence 
in the public, but they intimated that quality ratings were 
unlikely to influence their use of specific pharmacies. 
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They emphasised the need for multidimensional quality 
ratings and for transparency with their derivation.
strengths and weaknesses
We included a diverse range of participants in terms of 
country, sex and age, but not ethnicity. We were satis-
fied that our sample size was appropriate in terms 
of answering our research questions relating to the 
conceptualisation of quality and its measurement.22 One 
experienced health service researcher, who was also a 
pharmacist (MW), undertook all data collection. She did 
not disclose her pharmacist background unless specif-
ically asked. The breadth and depth of topics covered 
suggest that participants felt empowered to participate 
and share positive and negative experiences of commu-
nity pharmacy use. Data analysis was undertaken by two 
experienced qualitative researchers (KS, female and RW, 
male) neither of whom were pharmacists. This ensured a 
balanced approach to the analysis and interpretation of 
the data. Our interpretive analysis explored participants’ 
understanding and sense-making of their experiences of 
pharmacy services. We are confident that all key recurring 
themes were identified with no new themes emerging in 
the later interviews or focus groups.
Important differences in the results
None of the major themes derived from our study are 
reflected in the national quality indicators. This is perhaps 
unsurprising given that there was no PPI with indicator 
development. To date, there has been minimal PPI in 
the development of the few existing quality indicators for 
community pharmacy services.23–25 There has, however, 
been limited exploration of the likely influence of quality 
ratings on patient behaviour. Our participants antici-
pated that quality indicators would have little effect on 
their use of pharmacies, reflecting the results of two US 
studies that concurred that patients would only consider 
indicators if they were seeking a community pharmacy in 
a new area26–27.
Meaning of the study
Our results show that the public value relational aspects 
of care, that is, personnel who are friendly and approach-
able, and reflect a recent UK-wide survey of over 1000 
members of the public and their preferences for attri-
butes of community pharmacies when seeking care for 
minor ailments (aka self-care consultations).28 As with 
these survey respondents, our participants also prioritised 
ease of access and convenience as important attributes.
Implications for clinicians and policy-makers and unanswered 
questions and future research
Future quality indicator development should involve 
stakeholders, particularly patients and public, as the main 
users of community pharmacy. Despite a possible lack of 
effect on care-seeking behaviour, the use of coproduced 
indicators could be used to drive quality improvement 
within and between community pharmacies.
COnClusIOn
The public conceptualises quality of community phar-
macy services as multidimensional and they value rela-
tional aspects of care provided by personnel in this 
setting. While the development and application of quality 
indicators may drive improvement, it seems unlikely 
that they would influence the public’s use of individual 
pharmacies.
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